#PreMarket Loers

Gainers DelMar Pharmaceuticals Inc (NASDAQ: DMPI) shares rose 43.4 percent to $1.190 in pre-market trading after the company disclosed a FDA Fast Track designation for VAL-083 in recurrent glioblastoma. Aptose Biosciences Inc (NASDAQ: APTO) shares rose 20.8 percent to $2.11 in pre-market...